Mads Møller Pedersen, MSc

  • 1Article
  • 14.8KReads
  • 2023Active
  • 3Collaborators
  • 28Citations

About

Mads Møller Pedersen, MSc is affiliated with H. Lundbeck A/S, Valby, Denmark. Mads Møller Pedersen has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2023. Their work focuses on Depression (MDD).

Publications

JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

Vortioxetine vs Desvenlafaxine in Patients With MDD

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe